Armağan, B. Et Al. 2023. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center. Immunopharmacology and Immunotoxicology , vol.45, no.4 , 395-401.

Armağan, B., Atalar, E., Güven, S. C., Özdemir, B., Konak, H. E., Akyüz Dağlı, P., ... Erden, A.(2023). Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center. Immunopharmacology and Immunotoxicology , vol.45, no.4, 395-401.

Armağan, Berkan Et Al. "Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center," Immunopharmacology and Immunotoxicology , vol.45, no.4, 395-401, 2023

Armağan, Berkan Et Al. "Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center." Immunopharmacology and Immunotoxicology , vol.45, no.4, pp.395-401, 2023

Armağan, B. Et Al. (2023) . "Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center." Immunopharmacology and Immunotoxicology , vol.45, no.4, pp.395-401.

@article{article, author={Berkan Armağan Et Al. }, title={Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center}, journal={Immunopharmacology and Immunotoxicology}, year=2023, pages={395-401} }